Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Adult outcomes of childhood-onset rheumatic diseases

Abstract

A number of studies published over the past 10 years have examined the long-term health, functional and quality of life outcomes of adults with childhood-onset rheumatic diseases such as juvenile idiopathic arthritis, systemic lupus erythematosus, juvenile dermatomyositis and localized scleroderma. As increasing numbers of patients with these conditions survive into adulthood, understanding the adult outcomes of these pediatric conditions has become ever-more important. Identifying modifiable risk factors for poor outcomes is vital to improving care for these patients. In addition, as these conditions and their treatments can affect cardiovascular health, bone health and fertility, particular attention needs to be paid to these outcomes. Preparing patients and their families for a successful transition from pediatric to adult rheumatology care is an important first-step in the long-term management strategy for this expanding patient population.

Key Points

  • Understanding the long-term morbidity and mortality of childhood-onset rheumatic diseases is critical to improving outcomes

  • Existing studies have demonstrated that patients with childhood-onset rheumatic diseases are at increased risk of early morbidity and disability

  • It is essential that pediatric patients with a chronic rheumatic disease have a seamless transition from pediatric to adult rheumatology care

  • Prospective, longitudinal studies are needed to better characterize the outcomes of childhood-onset rheumatic diseases

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Minden, K. Adult outcomes of patients with juvenile idiopathic arthritis. Horm. Res. 72 (Suppl. 1), 20–25 (2009).

    Article  CAS  Google Scholar 

  2. Cassidy, J. T. & Petty, R. E. Textbook of Pediatric Rheumatology 5th edn (Elsevier Saunders, Philadelphia, 2005).

    Google Scholar 

  3. Bandeira, M. et al. Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus. Lupus 15, 515–520 (2006).

    Article  CAS  Google Scholar 

  4. Brunner, H. I. et al. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 58, 556–562 (2008).

    Article  Google Scholar 

  5. Brunner, H. I. et al. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum. 46, 436–444 (2002).

    Article  Google Scholar 

  6. Hersh, A. O. et al. Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum. 61, 13–20 (2009).

    Article  Google Scholar 

  7. Ravelli, A., Ruperto, N. & Martini, A. Outcome in juvenile onset systemic lupus erythematosus. Curr. Opin. Rheumatol. 17, 568–573 (2005).

    Article  Google Scholar 

  8. Tucker, L. B. et al. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br. J. Rheumatol. 34, 866–872 (1995).

    Article  CAS  Google Scholar 

  9. Tucker, L. B. et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case–control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 17, 314–322 (2008).

    Article  CAS  Google Scholar 

  10. Alarcón, G. S. et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum. 45, 191–202 (2001).

    Article  Google Scholar 

  11. Chalom, E. C. et al. Educational, vocational and socioeconomic status and quality of life in adults with childhood-onset SLE. Pediatr. Rheumatol. Online J. 2, 207–226 (2004).

    Google Scholar 

  12. Gonzalez, B. et al. Changes in the survival of patients with systemic lupus erythematosus in childhood: 30 years experience in Chile. Lupus 14, 918–923 (2005).

    Article  CAS  Google Scholar 

  13. Miettunen, P. M. et al. Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus. J. Rheumatol. 31, 1650–1654 (2004).

    PubMed  Google Scholar 

  14. Wang, L. C. et al. Retrospective analysis of mortality and morbidity of pediatric systemic lupus erythematosus in the past two decades. J. Microbiol. Immunol. Infect. 36, 203–208 (2003).

    PubMed  Google Scholar 

  15. Hersh, A. O. et al. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Arthritis Care Res. (Hoboken) 62, 1152–1159 (2010).

    Article  Google Scholar 

  16. Sanner, H. et al. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset. Rheumatology (Oxford) 48, 1541–1547 (2009).

    Article  Google Scholar 

  17. Peterson, L. S., Nelson, A. M. & Su, W. P. Classification of morphea (localized scleroderma). Mayo Clin. Proc. 70, 1068–1076 (1995).

    Article  CAS  Google Scholar 

  18. Peterson, L. S. et al. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960–1993. J. Rheumatol. 24, 73–80 (1997).

    CAS  PubMed  Google Scholar 

  19. Li, S. C. et al. Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists. J. Rheumatol. 37, 175–181 (2010).

    Article  Google Scholar 

  20. Baildam, E. M. et al. Influence of childhood scleroderma on physical function and quality of life. J. Rheumatol. 38, 167–173 (2011).

    Article  Google Scholar 

  21. Palmero, M. L. et al. En coup de sabre scleroderma and Parry–Romberg syndrome in adolescents: surgical options and patient-related outcomes. J. Rheumatol. 37, 2174–2179 (2010).

    Article  Google Scholar 

  22. Saxton-Daniels, S. & Jacobe, H. T. An evaluation of long-term outcomes in adults with pediatric-onset morphea. Arch. Dermatol. 146, 1044–1045 (2010).

    Article  Google Scholar 

  23. Flato, B. et al. The influence of patient characteristics, disease variables, and HLA alleles on the development of radiographically evident sacroiliitis in juvenile idiopathic arthritis. Arthritis Rheum. 46, 986–994 (2002).

    Article  Google Scholar 

  24. Pagnini, I. et al. Early predictors of juvenile sacroiliitis in enthesitis-related arthritis. J. Rheumatol. 37, 2395–2401 (2010).

    Article  Google Scholar 

  25. Stoll, M. L. et al. Spondyloarthritis in a pediatric population: risk factors for sacroiliitis. J. Rheumatol. 37, 2402–2408 (2010).

    Article  Google Scholar 

  26. Flato, B. et al. Long-term outcome and prognostic factors in enthesitis-related arthritis: a case–control study. Arthritis Rheum. 54, 3573–3582 (2006).

    Article  Google Scholar 

  27. Minden, K. et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum. 46, 2392–2401 (2002).

    Article  Google Scholar 

  28. Petty, R. E. et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J. Rheumatol. 25, 1991–1994 (1998).

    CAS  PubMed  Google Scholar 

  29. Flato, B. et al. Juvenile psoriatic arthritis: longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis. J. Rheumatol. 36, 642–650 (2009).

    Article  Google Scholar 

  30. Asanuma, Y. et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 349, 2407–2415 (2003).

    Article  CAS  Google Scholar 

  31. Duran, S., Gonzalez, L. A. & Alarcon, G. S. Damage, accelerated atherosclerosis, and mortality in patients with systemic lupus erythematosus: lessons from LUMINA, a multiethnic US cohort. J. Clin. Rheumatol. 13, 350–353 (2007).

    Article  Google Scholar 

  32. Salmon, J. E. & Roman, M. J. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am. J. Med. 121 (10 Suppl. 1): S3–S8 (2008).

    Article  Google Scholar 

  33. Falaschi, F. et al. Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum. 43, 1405–1409 (2000).

    Article  CAS  Google Scholar 

  34. Huang, Y. L. et al. Lymphopenia is a risk factor in the progression of carotid intima–media thickness in juvenile-onset systemic lupus erythematosus. Arthritis Rheum. 60, 3766–3775 (2009).

    Article  Google Scholar 

  35. Ardoin, S. P. et al. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort. Lupus 19, 1315–1325 (2010).

    Article  CAS  Google Scholar 

  36. Schanberg, L. E. et al. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima–media thickness in the Atherosclerosis Prevention in Pediatric Lupus Erythematosus cohort. Arthritis Rheum. 60, 1496–1507 (2009).

    Article  Google Scholar 

  37. Schanberg, L. E. et al. Does atorvastatin reduce progression of carotid intimal medial thickening (CIMT) in childhood SLE? Results from the Atherosclerosis Prevention in Pediatric Lupus (APPLE) trial: a multicenter, randomized, double-blind placebo-controlled study [abstract 1677]. Arthritis Rheum. 62 (Suppl.), S699 (2010).

    Google Scholar 

  38. Cimaz, R. Osteoporosis in childhood rheumatic diseases: prevention and therapy. Best Pract. Res. Clin. Rheumatol. 16, 397–409 (2002).

    Article  Google Scholar 

  39. Hamalainen, H. et al. Bone mineral content in young adults with active or inactive juvenile idiopathic arthritis and in controls. Scand. J. Rheumatol. 39, 219–222 (2010).

    Article  CAS  Google Scholar 

  40. Haugen, M. et al. Young adults with juvenile arthritis in remission attain normal peak bone mass at the lumbar spine and forearm. Arthritis Rheum. 43, 1504–1510 (2000).

    Article  CAS  Google Scholar 

  41. Lilleby, V. et al. Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus. Arthritis Rheum. 52, 2051–2059 (2005).

    Article  Google Scholar 

  42. Aikawa, N. E. et al. Menstrual and hormonal alterations in juvenile dermatomyositis. Clin. Exp. Rheumatol. 28, 571–575 (2010).

    CAS  PubMed  Google Scholar 

  43. Packham, J. C. & Hall, M. A. Premature ovarian failure in women with juvenile idiopathic arthritis (JIA). Clin. Exp. Rheumatol. 21, 347–350 (2003).

    CAS  PubMed  Google Scholar 

  44. Brunner, H. I. et al. Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus. Lupus 15, 198–206 (2006).

    Article  CAS  Google Scholar 

  45. Medeiros, P. B. et al. Menstrual and hormonal alterations in juvenile systemic lupus erythematosus. Lupus 18, 38–43 (2009).

    Article  CAS  Google Scholar 

  46. Silva, C. A. & Brunner, H. I. Gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus. Lupus 16, 593–599 (2007).

    Article  CAS  Google Scholar 

  47. Ostlie, I. L., Dale, O. & Möller, A. From childhood to adult life with juvenile idiopathic arthritis (JIA): a pilot study. Disabil. Rehabil. 29, 445–452 (2007).

    Article  Google Scholar 

  48. Hazel, E. et al. High rates of unsuccessful transfer to adult care among young adults with juvenile idiopathic arthritis. Pediatr. Rheumatol. Online J. 8, 2 (2010).

    Article  Google Scholar 

  49. Hilderson, D. et al. Adolescents with juvenile idiopathic arthritis: who cares after the age of 16? Clin. Exp. Rheumatol. 28, 790–797 (2010).

    CAS  PubMed  Google Scholar 

  50. Hersh, A. O. et al. The challenges of transferring chronic illness patients to adult care: reflections from pediatric and adult rheumatology at a US academic center. Pediatr. Rheumatol. Online J. 7, 13 (2009).

    Article  Google Scholar 

Download references

Acknowledgements

Dr. Hersh's research on the adult outcomes of childhood-onset rheumatic disease is generously supported by the American College of Rheumatology Research and Education Foundation Rheumatology Investigator Award. C. P. Vega, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the Medscape, LLC-accredited continuing medical education activity associated with this article.

Author information

Authors and Affiliations

Authors

Contributions

A. Hersh researched data for and wrote the article. All authors made substantial contributions to discussion of the content and to review/editing of the manuscript before submission.

Corresponding author

Correspondence to Aimee Hersh.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hersh, A., von Scheven, E. & Yelin, E. Adult outcomes of childhood-onset rheumatic diseases. Nat Rev Rheumatol 7, 290–295 (2011). https://doi.org/10.1038/nrrheum.2011.38

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2011.38

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing